Medication info
Omecapsule (Omeprazole)

Omecapsule (Omeprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Omeprazole Enteric Coated Granules›230mg / 1 capsule
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
A hard capsule with a purple upper and lower part filled with white to light yellow-brown enteric-coated spherical granules.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 199700548 · Notified 1997.04.21 · Insurance code 642901440

Summary

Main use
Treatment and prevention of gastrointestinal disorders (ulcers, reflux, indigestion, etc.) and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
1) Gastric ulcer: Administer 20mg of omeprazole orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. 2) Short-term treatment of duodenal ulcer: Administer 20mg orally once daily. Most cases may heal within 2 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 2 weeks of treatment, continue treatment for an additional 2 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 4 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. 3) Treatment of reflux esophagitis and symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): - Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. - Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Healing is generally possible with treatment for 2~4 weeks. 4) Maintenance therapy for severe reflux esophagitis and peptic ulcers that are difficult to treat: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 5) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment, adjusting the dose appropriately for each individual. More than 90% of patients respond to doses of 20 - 120mg per day. If administering more than 80mg per day, divide the dose into 2 administrations daily. 6) Antibiotic combination therapy to prevent recurrence of duodenal ulcers infected with Helicobacter pylori: - Dual therapy: Administer this medicine 20mg with amoxicillin 750 - 1000mg twice daily for 2 weeks. - Triple therapy: Administer this medicine 40mg once daily or 20mg twice daily in combination with the following antibiotics. ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment effect is insufficient, omeprazole monotherapy may be continued. 7) Treatment of gastric or duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. 8) Maintenance therapy for the prevention of gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID use in patients receiving long-term NSAID therapy who have a history of gastric or duodenal lesions: Administer 20mg orally once daily. 9) Prevention of recurrence of reflux esophagitis: Administer 10mg orally once daily to prevent recurrence of reflux esophagitis. * Swallow this medicine whole with at least half a glass of water. The dose may be increased or decreased as appropriate according to age and symptoms.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of gastrointestinal disorders (ulcers, reflux, indigestion, etc.) and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • heartburn
  • regurgitation
  • severe gastroesophageal reflux disease
  • peptic ulcers
  • duodenal ulcers
  • gastric ulcers
  • duodenal ulcers
  • erosions
  • dyspepsia symptoms
  • gastroesophageal reflux disease
View approved original text

This medication is used for the short-term treatment of gastric ulcers and duodenal ulcers. It is also effective in relieving symptoms of gastroesophageal reflux disease and reflux esophagitis, such as heartburn and regurgitation. It is used as maintenance therapy for severe gastroesophageal reflux disease or difficult-to-treat peptic ulcers and can assist in the treatment of Zollinger-Ellison syndrome. It may be administered in combination with antibiotics to prevent recurrence of duodenal ulcers caused by Helicobacter pylori infection. It is also used for the treatment of gastric and duodenal ulcers and erosions induced by non-steroidal anti-inflammatory drugs (NSAIDs) and for the prevention in patients with such a history. It is effectively utilized for the treatment and prevention of various gastrointestinal disorders.

How to take

Adult dose

1) Gastric ulcer: Administer 20mg of omeprazole orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. 2) Short-term treatment of duodenal ulcer: Administer 20mg orally once daily. Most cases may heal within 2 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 2 weeks of treatment, continue treatment for an additional 2 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 4 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. 3) Treatment of reflux esophagitis and symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): - Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary occasionally from patient to patient. Repeat treatment if the condition recurs. - Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Healing is generally possible with treatment for 2~4 weeks. 4) Maintenance therapy for severe reflux esophagitis and peptic ulcers that are difficult to treat: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 5) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment, adjusting the dose appropriately for each individual. More than 90% of patients respond to doses of 20 - 120mg per day. If administering more than 80mg per day, divide the dose into 2 administrations daily. 6) Antibiotic combination therapy to prevent recurrence of duodenal ulcers infected with Helicobacter pylori: - Dual therapy: Administer this medicine 20mg with amoxicillin 750 - 1000mg twice daily for 2 weeks. - Triple therapy: Administer this medicine 40mg once daily or 20mg twice daily in combination with the following antibiotics. ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment effect is insufficient, omeprazole monotherapy may be continued. 7) Treatment of gastric or duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary occasionally from patient to patient. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. 8) Maintenance therapy for the prevention of gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID use in patients receiving long-term NSAID therapy who have a history of gastric or duodenal lesions: Administer 20mg orally once daily. 9) Prevention of recurrence of reflux esophagitis: Administer 10mg orally once daily to prevent recurrence of reflux esophagitis. * Swallow this medicine whole with at least half a glass of water. The dose may be increased or decreased as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients who are allergic to its components. Caution should be exercised in administering it to patients with gastric ulcers suspected to be malignant, as it may delay disease diagnosis. It cannot be combined with certain antiviral medications, so you must inform your doctor if you are taking any other medications. Patients with impaired liver function should reduce the dosage; particularly, those with severe hepatic impairment should not exceed 20mg per day. Elderly patients or those with allergies to certain dye components should also use it cautiously. Neurological symptoms such as headaches, dizziness, and drowsiness may occur, and liver function abnormalities or gastrointestinal disturbance symptoms should be carefully monitored. Skin rashes or itching, and in severe cases severe skin reactions may occur, necessitating immediate discontinuation of use in case of unusual symptoms. Patients with renal disease should be cautious as this medication may affect kidney function. Long-term use may increase the risk of fractures and lower magnesium levels, requiring regular testing. Many medications interact with this drug, so if you are taking other medications, you must inform your doctor, especially with anticoagulants, anticonvulsants, and immunosuppressants. Women who are pregnant or may become pregnant should carefully weigh the benefits and risks of using this medication. It is advisable to avoid this medication while breastfeeding; in unavoidable circumstances, nursing should be discontinued. It is preferable not to use it in children as its safety has not been established. Overdose may cause symptoms such as vomiting, diarrhea, and headaches, although these are generally temporary. This medication should be stored out of the reach of children, kept in its original container, and tightly closed.

Side effects

Headache, drowsiness, dizziness, insomnia, paresthesia, feeling faint, lightheadedness, confusion, excitement, aggressiveness, hallucinations, depression, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, interstitial nephritis, diarrhea, colitis, constipation, nausea, vomiting, abdominal pain, abdominal bloating, dry mouth, stomatitis, gastrointestinal candidiasis, erythema, rash, papules, hives, itching, dermatitis, vesicular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, photosensitivity, alopecia, angioedema, fever, bronchospasm, interstitial nephritis, anaphylactic shock, chest pain, tachycardia, bradycardia, palpitations, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, back pain, arthralgia, muscle weakness, myalgia, gynecomastia, cough, fatigue, malaise, peripheral edema, increased sweating, blurry vision, vision impairment, taste disorder, breast pain, breast lump, hyponatremia, erectile dysfunction, Clostridium difficile-associated diarrhea, hypomagnesemia, acute generalized exanthematous pustulosis, eosinophilia, systemic drug reaction with systemic symptoms, systemic lupus erythematosus, discoid lupus erythematosus, gastric polyp, hypocalcemia, hypokalemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing it in excessively hot or cold places and keep it at room temperature.

Appearance and packaging

Appearance

A hard capsule with a purple upper and lower part filled with white to light yellow-brown enteric-coated spherical granules.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.